FDA solicits feedback on distracting elements of drug ads

02/6/2012 | Xconomy

The FDA reopened the comment period on its proposed rule for direct-to-consumer marketing of prescription drugs. The decision follows the release of an agency-sponsored study that assessed the impact of distracting images or statements in ads on consumers' understanding of information about drug risks and benefits.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ